Thank god for government R&D grants .... seems to be the only way Starpharma makes a profit these days given the SPL7013 revenues / Receipts from Customers has decreased by almost $400,000 since the June Quarterly but hey tell us all again Cheryl how you were focusing on "Advertising and Marketing" of the SPL7013 products ?
September Quarter $650,000
June Quarterly $1,040,000
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.005(5.26%) |
Mkt cap ! $41.40M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.0¢ | 9.9¢ | $40.8K | 409.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 81544 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 284456 | 5 |
View Market Depth
| Last trade - 13.56pm 31/07/2025 (20 minute delay) ? |
| SPL (ASX) Chart |